系统性红斑狼疮患者死亡率的时序趋势:一项丹麦人群匹配队列研究
该丹麦全国人群匹配队列研究纳入1996至2015年诊断的1351例SLE患者和6755名匹配对照,随访至2020年。5年死亡率粗风险差从10.3%降至4.6%,相对风险也下降;但10年死亡率的风险差和相对风险未随时间变化,且年轻患者10年相对风险最高。
要点
- 5年死亡率粗风险差从10.3%(95%CI 6.5-14.1%)降至4.6%(95%CI 1.4-7.8%)。
- 5年死亡率相对风险同期也下降,调整合并症后下降趋势仍存在。
- 10年死亡率的风险差和相对风险未随时间变化,年轻患者10年相对风险最高。
核心结论
- SLE患者和匹配对照的5年死亡风险均随时间下降,但近期SLE患者仍有超额5年死亡率,且病程晚期超额死亡率持续存在。
- 作者认为需要继续关注预防疾病进展和合并症。
研究设计与样本
- 丹麦全国人群暴露匹配队列研究,利用行政健康登记识别1996至2015年诊断的SLE新发病例并随访至2020年。
- SLE患者按年龄和性别与丹麦一般人群1:5匹配,采用伪观察方法进行时间-事件分析。
- 共纳入1351例SLE新发病例和6755名匹配对照。
主要发现
- 5年死亡率粗风险差从10.3%(95%CI 6.5-14.1%)降至4.6%(95%CI 1.4-7.8%)。
- 5年死亡率相对风险同期也下降,调整合并症后风险差和相对风险更低,但下降趋势仍存在。
- 10年死亡率粗和调整风险差及相对风险在日历期间未变化。
- 10年相对风险在年轻SLE患者(<50岁)中最高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Excess mortality has been demonstrated in patients with SLE compared with the general population. We aimed to investigate the 5-year and 10-year all-cause mortality in patients with SLE compared with the general population in recent decades. METHODS: This was a Danish nationwide population-based exposure-matched cohort study. Incident cases of SLE diagnosed between 1996 and 2015 were identified using administrative health registries and followed until 2020, allowing for 5 and 10 years of follow-up. Patients with SLE were matched 1:5 on age and sex with individuals from the Danish general population. Time-to-event analyses were performed using the pseudo-observation approach. RESULTS: In total, 1351 incident cases of SLE and 6755 matched controls were identified. The crude risk difference (RD) for 5-year mortality decreased over the study period, from 10.3% (95% CI 6.5-14.1%) to 4.6% (95% CI 1.4-7.8%) for patients with SLE compared with controls. The relative risk (RR) for 5-year mortality decreased similarly in the same period. Adjustment for comorbidities revealed lower RD and RR for mortality in patients with SLE compared with controls, but the decreasing trend remained. The crude and adjusted RD and RR for 10-year mortality did not change over the calendar period. The 10-year RR was highest in young patients with SLE (<50 years of age). CONCLUSION: The 5-year mortality risk decreased over time for both patients with SLE and matched controls. However, excess 5-year mortality for patients with SLE in the most recent calendar period and excess mortality late in their disease course remained. Continued focus on preventing disease progression and comorbidity is required.
引用
- Kristensen S, Duch K, Soussi BG, et al. Temporal trends in mortality in patients with systemic lupus erythematosus: a Danish population-based matched cohort study. Rheumatology (Oxford). 2024. PMID: 38656941. doi:10.1093/rheumatology/keae244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。